DK190989A - Fremgangsmaade til fremstilling af antigener - Google Patents
Fremgangsmaade til fremstilling af antigenerInfo
- Publication number
- DK190989A DK190989A DK190989A DK190989A DK190989A DK 190989 A DK190989 A DK 190989A DK 190989 A DK190989 A DK 190989A DK 190989 A DK190989 A DK 190989A DK 190989 A DK190989 A DK 190989A
- Authority
- DK
- Denmark
- Prior art keywords
- adenylate cyclase
- preparation
- calmodulin
- pertussis
- kda
- Prior art date
Links
- 239000000427 antigen Substances 0.000 title 1
- 102000036639 antigens Human genes 0.000 title 1
- 108091007433 antigens Proteins 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 102000030621 adenylate cyclase Human genes 0.000 abstract 8
- 108060000200 adenylate cyclase Proteins 0.000 abstract 8
- 241000588780 Bordetella parapertussis Species 0.000 abstract 1
- 241000588832 Bordetella pertussis Species 0.000 abstract 1
- 102000000584 Calmodulin Human genes 0.000 abstract 1
- 108010041952 Calmodulin Proteins 0.000 abstract 1
- 108010058846 Ovalbumin Proteins 0.000 abstract 1
- 201000005702 Pertussis Diseases 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 230000002163 immunogen Effects 0.000 abstract 1
- 229940092253 ovalbumin Drugs 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/235—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Bordetella (G)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/88—Lyases (4.)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/814—Enzyme separation or purification
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Wood Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biophysics (AREA)
- General Engineering & Computer Science (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Enzymes And Modification Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP88400949 | 1988-04-19 | ||
| EP88400949A EP0338169B1 (en) | 1988-04-19 | 1988-04-19 | Method for obtaining protective antigens against bordetella infections and toxic processes |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| DK190989D0 DK190989D0 (da) | 1989-04-19 |
| DK190989A true DK190989A (da) | 1989-10-20 |
| DK175663B1 DK175663B1 (da) | 2005-01-10 |
Family
ID=8200381
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK198901909A DK175663B1 (da) | 1988-04-19 | 1989-04-19 | Fremgangsmåde til opnåelse af beskyttende antigener mod Bordetalla-infektioner og toxiske processer |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US5595901A (da) |
| EP (2) | EP0338169B1 (da) |
| JP (1) | JP2999480B2 (da) |
| AT (1) | ATE140729T1 (da) |
| CA (1) | CA1341332C (da) |
| DE (1) | DE3855442T2 (da) |
| DK (1) | DK175663B1 (da) |
| ES (1) | ES2091186T3 (da) |
| GR (1) | GR3021331T3 (da) |
| PT (1) | PT90310B (da) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2646776B1 (fr) * | 1989-05-12 | 1994-06-03 | Pasteur Institut | Utilisation de preparations vaccinantes a base d'adenyl cyclase ou de bacteries les produisant en tant qu'antigenes protecteurs contre les effets des bordetella |
| US6338963B1 (en) | 1994-07-25 | 2002-01-15 | Neotherapeutics, Inc. | Use of carbon monoxide dependent guanylyl cyclase modifiers to stimulate neuritogenesis |
| FR2728170A1 (fr) | 1994-12-15 | 1996-06-21 | Pasteur Institut | Vaccin de type acellulaire anti-bordetella |
| US6030625A (en) * | 1994-12-15 | 2000-02-29 | Institut Pasteur | Bordetella pertussis and Bordetella parapertussis strains |
| FR2736064B1 (fr) | 1995-06-30 | 1997-09-05 | Pasteur Institut | Epitopes protecteurs de l'adenyl cyclase-hemolysine(ac-hty). leur application au traitement ou a la prevention des infections par bordetella |
| AU3786299A (en) | 1998-05-04 | 1999-11-23 | Neotherapeutics, Inc. | Novel serotonin-like 9-substituted hypoxanthine and methods of use |
| US6288069B1 (en) | 1999-11-16 | 2001-09-11 | Neotherapeutics, Inc. | Use of 9-substituted hypoxanthine derivatives to stimulate regeneration of nervous tissue |
| US6407237B1 (en) | 2001-02-21 | 2002-06-18 | Neotherapeutics, Inc. | Crystal forms of 9-substituted hypoxanthine derivatives |
| US6849735B1 (en) | 2000-06-23 | 2005-02-01 | Merck Eprova Ag | Methods of synthesis for 9-substituted hypoxanthine derivatives |
| WO2002004452A2 (en) | 2000-07-07 | 2002-01-17 | Neotherapeutics, Inc. | Methods for treatment of disease-induced peripheral neuropathy and related conditions |
| US6759427B2 (en) | 2001-04-20 | 2004-07-06 | Spectrum Pharmaceuticals, Inc. | Synthesis and methods of use of tetrahydroindolone analogues and derivatives |
| US20030055249A1 (en) * | 2001-07-17 | 2003-03-20 | Fick David B. | Synthesis and methods of use of pyrimidine analogues and derivatives |
| US7462472B2 (en) * | 2001-11-02 | 2008-12-09 | The University Of Chicago | Methods and compositions relating to anthrax pathogenesis |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8412207D0 (en) * | 1984-05-12 | 1984-06-20 | Wellcome Found | Antigenic preparations |
| FR2606789B1 (fr) * | 1986-11-17 | 1991-05-31 | Pasteur Institut | Preparations d'adenylate cyclase purifiees, procede d'obtention de ces preparations et leurs applications biologiques |
| EP0338170A1 (en) * | 1988-04-19 | 1989-10-25 | Institut Pasteur | Immunoprotective antigenic protein against pathogenic bacteria |
| US5312749A (en) * | 1992-05-12 | 1994-05-17 | The United States Of America As Represented By The Secretary Of Agriculture | Industrial alkaline protease from shipworm bacterium |
-
1988
- 1988-04-19 DE DE3855442T patent/DE3855442T2/de not_active Expired - Fee Related
- 1988-04-19 EP EP88400949A patent/EP0338169B1/en not_active Expired - Lifetime
- 1988-04-19 ES ES88400949T patent/ES2091186T3/es not_active Expired - Lifetime
- 1988-04-19 AT AT88400949T patent/ATE140729T1/de not_active IP Right Cessation
- 1988-04-19 EP EP95111293A patent/EP0691348A1/en not_active Withdrawn
-
1989
- 1989-04-18 JP JP1096538A patent/JP2999480B2/ja not_active Expired - Fee Related
- 1989-04-19 DK DK198901909A patent/DK175663B1/da not_active IP Right Cessation
- 1989-04-19 CA CA000597153A patent/CA1341332C/en not_active Expired - Fee Related
- 1989-04-19 PT PT90310A patent/PT90310B/pt active IP Right Grant
-
1995
- 1995-06-06 US US08/466,882 patent/US5595901A/en not_active Expired - Fee Related
-
1996
- 1996-10-10 GR GR960402700T patent/GR3021331T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JPH02131432A (ja) | 1990-05-21 |
| DK175663B1 (da) | 2005-01-10 |
| PT90310B (pt) | 1994-09-30 |
| EP0691348A1 (en) | 1996-01-10 |
| ATE140729T1 (de) | 1996-08-15 |
| DE3855442D1 (de) | 1996-08-29 |
| US5595901A (en) | 1997-01-21 |
| JP2999480B2 (ja) | 2000-01-17 |
| EP0338169A1 (en) | 1989-10-25 |
| DE3855442T2 (de) | 1997-03-06 |
| ES2091186T3 (es) | 1996-11-01 |
| EP0338169B1 (en) | 1996-07-24 |
| CA1341332C (en) | 2002-01-08 |
| GR3021331T3 (en) | 1997-01-31 |
| PT90310A (pt) | 1989-11-10 |
| DK190989D0 (da) | 1989-04-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK190989A (da) | Fremgangsmaade til fremstilling af antigener | |
| DK0473671T3 (da) | Anvendelse af sigma-receptorligander til fremstilling af et anxiolytisk middel | |
| NO20003716D0 (no) | Protein D for anvendelse in vitro, renset antistoff som binder proteinet, samt anvendelser derav | |
| GR3036906T3 (en) | Monoclonal antibody which specifically binds to tumor vascular endothelium and uses thereof. | |
| NO165478C (no) | Fremgangsmaate for fremstilling av antigeniske preparater. | |
| KR900700132A (ko) | 면역 글로불린 e 반응 억제 방법 | |
| DK0754229T3 (da) | Afamin: et humant serum albumin-lignende protein | |
| Agui et al. | Binding of Clostridium botulinum type C neurotoxin to rat brain synaptosomes | |
| FI873410A (fi) | Kahden uuden hybridooman tuottamia apolipoproteiini-B-spesifisiä monoklonaalisia vasta-aineita | |
| YU48525B (sh) | Protein, dnk koji kodira protein, rekombinantni vektor koji obuhvata dnk i postupak za proizovodnju proteina | |
| DE3885365D1 (de) | Spezifische Sekretions-Exkretions-Antigene von Toxoplasma gondii, deren Expressionsprodukte, Verfahren zu deren Herstellung und deren diagnostische und prophylaktische Anwendungen. | |
| DK81691D0 (da) | Fremgangsmaade til forhindring eller reduktion af eosinofili | |
| AU2032988A (en) | A genus-specific listeria antigen identified by monoclonal antibodies | |
| NO972522L (no) | Monoklonale antistoffer med immunoundertrykkende aktivitet | |
| DK270389D0 (da) | Lyofiliseret igm-koncentrat | |
| JPS54113422A (en) | Hemagglutinin of haemophilus gallinarum | |
| SE9300139D0 (sv) | Manufacture of a new drug | |
| DK0513565T3 (da) | Monoklonale antistoffer mod plasmin-antiplasmin-komplekset, fremgangsmåde til deres fremstilling og deres anvendelse | |
| ES546594A0 (es) | Un procedimiento para preparar un anticuerpo monocional anti-urocinasa. | |
| Ostermann-Latif et al. | An efficient sandwich-ELISA for the determination of choline acetyltransferase | |
| DK0542895T3 (da) | Krydsreaktiv influenza A immunisering | |
| SE7904276L (sv) | Renat cancerassocierat protein | |
| ES2148248T3 (es) | Peptidos de la lipoproteina (a) y su utilizacion. | |
| YOSHIDA et al. | NEUTRALIZATION OF TOXICITY OF TETANUS TOXIN INDUCED BY MONOCLONAL ANTIBODIES | |
| TH13147EX (th) | อนุพันธ์ของฮีสตามีนและวิธีการใช้มันเพื่อเป็นตัวเปลี่ยนแปลงแบบอิมมูน |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PBP | Patent lapsed |
Country of ref document: DK |